ACANTHE BIOTECH

Pdf

ACANTHE BIOTECH

Category

  • Start-up

Location

  • 75014
  • Paris
  • France

Description d'activité

  • Obtaining monoclonal antibodies for the treatment of human bladder
    Tumors linked to Auristatin.
    Animal trials are in progress.
    New Bispecifiques antibodies against bladder are in progress.

Landmarks

  • Turnover : < 2 M€
  • Staff : 0 - 9

Group / Member of

Participants

LE avatar

Lena EDELMAN

President

MG avatar

Marie GLOMET

Objectives

Needs

  •  R&D
  • Technology Platform
  • Financing Innovation

SPECIFIC INFORMATION ON THE NATURE OF THE OFFER

Laboratoire biochimie pour identifier la cible des Anticorps
.Structure avec Anticorps monoclonaux qui permettraient l assemblage de nouveaux Anticorps bispecifiques

Application fields

    Application fields

Skills

9. Medical and health technologies
  • 9.1 Investigation
  • Biotechnologies
  • Biochemical detection
  • 9.3 Therapeutic follow-up
  • Therapeutic follow-up
  • 9.5 Clinical Trials
  • Clinical Trials
14. Support for innovation and R & D partnerships
  • 14.1 Support for innovation and R & D partnerships
  • Support for collaborative project setting up
  • R&D funding